Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

CMS Suspends Albuterol Payment Cuts Under Medicare Part B

Executive Summary

The Centers for Medicare & Medicaid Services will reconsider Medicare carrier payment reductions for albuterol, the agency's Dec. 13 inherent reasonableness interim final rule says

You may also be interested in...



Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says

The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says

Medicare “Inherent Reasonableness” Standard Should Be Clarified, BIO Says

The Centers for Medicare & Medicaid Services should clarify its guidelines for applying the "inherent reasonableness" standard to coverage decisions, the Biotechnology Industry Organization says

Medicare Rx "overpayment" reforms may be sought by Administration to finance program expansion.

MEDICARE Rx DRUG "OVERPAYMENTS" MAY BE TARGETED FOR MEDICARE EXPANSION FUNDING, Health Care Financing Administration chief Nancy-Ann Min DeParle said at a National Health Council briefing Jan. 7 in Washington, D.C. In President Clinton's Jan. 6 announcement of a proposal to expand the availability of Medicare coverage, he said that the short-term financial impact of the expansion will be offset by savings from new Medicare fraud and abuse proposals contained in his fiscal 1999 budget. The budget usually is delivered to Congress during the first week in February.

Latest Headlines
See All
UsernamePublicRestriction

Register

PS040938

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel